- Targeted stakeholdersIncreased public awareness could lead to earlier diagnoses and earlier treatment for some patients.
- Targeted stakeholdersEncourages expanded provider education and more culturally competent clinical care for diverse patients.
- Targeted stakeholdersMay stimulate additional research funding and development of updated clinical guidelines.
Supporting the designation of March 2026 as Endometriosis Awareness Month.
Referred to the House Committee on Energy and Commerce.
This simple House resolution designates March 2026 as Endometriosis Awareness Month.
It recognizes the prevalence and burdens of endometriosis, calls for earlier detection, provider education, culturally competent care, and increased research funding, and encourages public awareness activities.
The resolution is non-binding and does not itself appropriate funds or create new federal programs.
This is a House simple resolution (symbolic) that does not create law or require presidential signature, so it cannot become law as written.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly describes the health issue and expresses support for an awareness month. It correctly confines itself to nonbinding statements of recognition and encouragement and does not attempt to create new authorities or appropriate funds.
Liberals push for concrete federal research funding; conservatives prefer private/state solutions
Who stands to gain, and who may push back.
- Targeted stakeholdersThe resolution is symbolic and creates no binding funding, regulatory, or legal requirements.
- Targeted stakeholdersIt does not appropriate funds or change taxes, so immediate fiscal effects are negligible.
- Targeted stakeholdersMay raise public expectations for new services or funding that are not guaranteed.
Why the argument around this bill splits.
Liberals push for concrete federal research funding; conservatives prefer private/state solutions
Likely strongly supportive.
The resolution highlights a women's health issue, calls for more research, provider education, and culturally competent care — priorities for progressive health advocates.
Supporters will welcome attention to diagnostic delays, economic burdens, and calls to fund research.
Generally positive and likely supportive, seeing the resolution as a low-cost, noncontroversial recognition of a public-health problem.
Centrists will appreciate attention to workforce impacts and diagnostic delays but may look for concrete, budgeted follow-ups rather than symbolic language alone.
Likely supportive but somewhat reserved; the resolution is a nonbinding awareness measure focused on a medical condition affecting constituents.
Conservatives will back awareness and improved care while stressing limited federal role and caution about open-ended research spending commitments.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
This is a House simple resolution (symbolic) that does not create law or require presidential signature, so it cannot become law as written.
- Whether House leadership will prioritize scheduling for a floor vote
- Whether a companion Senate resolution will be introduced or considered
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberals push for concrete federal research funding; conservatives prefer private/state solutions
This is a House simple resolution (symbolic) that does not create law or require presidential signature, so it cannot become law as written.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly describes the health issue and expresses support for an awareness month. It correctly confines itself to no…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.